The RADS-Panacea or Pain?

doi:10.1055/s-0042-1755236

Editorial

. 2022 Jul 30;32(2):149-150.

doi: 10.1055/s-0042-1755236. eCollection 2022 Jun.

The RADS-Panacea or Pain?

Ravikanth Balaji

PMID: 35924132
PMCID: PMC9340186
DOI: 10.1055/s-0042-1755236

Editorial

The RADS-Panacea or Pain?

Ravikanth Balaji. Indian J Radiol Imaging. 2022.

. 2022 Jul 30;32(2):149-150.

doi: 10.1055/s-0042-1755236. eCollection 2022 Jun.

Author

Ravikanth Balaji

PMID: 35924132
PMCID: PMC9340186
DOI: 10.1055/s-0042-1755236

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None.

Similar articles

In the Setting of Negative Mammogram, Is Additional Breast Ultrasound Necessary for Evaluation of Breast Pain?
Mema E, Cho E, Ryu YK, Jadeja P, Wynn R, Taback B, Ha R. Mema E, et al. Curr Probl Diagn Radiol. 2019 Mar-Apr;48(2):117-120. doi: 10.1067/j.cpradiol.2017.12.007. Epub 2018 Jan 9. Curr Probl Diagn Radiol. 2019. PMID: 29402490
Lack of Incremental Prognostic Value of Pericoronary Adipose Tissue Computed Tomography Attenuation Beyond Coronary Artery Disease Reporting and Data System for Major Adverse Cardiovascular Events in Patients With Acute Chest Pain.
Wen D, Ren Z, Xue R, An R, Xu J, Li J, Zheng M. Wen D, et al. Circ Cardiovasc Imaging. 2023 Jul;16(7):536-544. doi: 10.1161/CIRCIMAGING.122.015120. Epub 2023 Jun 29. Circ Cardiovasc Imaging. 2023. PMID: 37381909 Free PMC article.
White spot syndrome virus in decapods from Mississippi Sound, USA, and susceptibility of Palaemonetes pugio and Uca panacea to a Chinese isolate.
Muhammad M, Lotz JM, Blaylock RB, Curran SS. Muhammad M, et al. Dis Aquat Organ. 2020 Mar 12;138:121-131. doi: 10.3354/dao03449. Dis Aquat Organ. 2020. PMID: 32162610
Rare adipose disorders (RADs) masquerading as obesity.
Herbst KL. Herbst KL. Acta Pharmacol Sin. 2012 Feb;33(2):155-72. doi: 10.1038/aps.2011.153. Acta Pharmacol Sin. 2012. PMID: 22301856 Free PMC article. Review.
Coronary Artery Disease - Reporting and Data System (CAD-RADS): An Expert Consensus Document of SCCT, ACR and NASCI: Endorsed by the ACC.
Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, Dill KE, Jacobs JE, Maroules CD, Rubin GD, Rybicki FJ, Schoepf UJ, Shaw LJ, Stillman AE, White CS, Woodard PK, Leipsic JA. Cury RC, et al. JACC Cardiovasc Imaging. 2016 Sep;9(9):1099-1113. doi: 10.1016/j.jcmg.2016.05.005. JACC Cardiovasc Imaging. 2016. PMID: 27609151 Review.

See all similar articles

References

1. American College of Radiology Reporting and Data Systems (RADS)Accessed July 7, 2022 from:https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems
1. Kumar I, Chaudhary S K, Shukla R C, Mani N, Verma A. Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1. Indian J Radiol Imaging. 2022;32(02):XX–XX. - PMC - PubMed
1. Schaudinn A, Gawlitza J, Mucha S et al.Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard. Eur J Radiol. 2019;116:180–185. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] American College of Radiology Reporting and Data Systems (RADS)Accessed July 7, 2022 from:https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems

[2] American College of Radiology Reporting and Data Systems (RADS)Accessed July 7, 2022 from:https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems

[3] Kumar I, Chaudhary S K, Shukla R C, Mani N, Verma A. Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1. Indian J Radiol Imaging. 2022;32(02):XX–XX. - PMC - PubMed

[4] Kumar I, Chaudhary S K, Shukla R C, Mani N, Verma A. Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1. Indian J Radiol Imaging. 2022;32(02):XX–XX. - PMC - PubMed

[5] Schaudinn A, Gawlitza J, Mucha S et al.Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard. Eur J Radiol. 2019;116:180–185. - PubMed

[6] Schaudinn A, Gawlitza J, Mucha S et al.Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard. Eur J Radiol. 2019;116:180–185. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The RADS-Panacea or Pain?

The RADS-Panacea or Pain?

Author

Conflict of interest statement

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources